Risk factors for multiple sclerosis and associations with anti-EBV antibody titers

dc.contributor.authorMouhieddine, Tarek H.
dc.contributor.authorDarwish, Hala
dc.contributor.authorFawaz, Lama M.
dc.contributor.authorYamout, Bassem I.
dc.contributor.authorTamim, Hani Mohammed
dc.contributor.authorKhoury, Samia J.
dc.contributor.departmentNeurology
dc.contributor.departmentClinical Research Institute
dc.contributor.departmentMultiple Sclerosis Center
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:07:28Z
dc.date.available2025-01-24T12:07:28Z
dc.date.issued2015
dc.description.abstractMultiple sclerosis (MS) is an inflammatory demyelination of the central nervous system. We investigated the prevalence of EBV seropositivity and other known risk factors for MS (age, smoking, low vitamin D) and their effect on anti-EBV antibody titers. We retrospectively studied 249 MS patients receiving care at the American University of Beirut Medical Center and 230 controls, during 2010-2014. EBV seropositivity was higher in MS patients compared to controls for both anti-VCA (99.5%; 97.2%) and anti-EBNA-1 (96.3%; 89.4%), and the titers were significantly higher in MS patients. MS patients had a significantly lower vitamin D level (15.5. ±. 8.3. ng/ml) compared to controls (20.4. ±. 11.3. ng/ml). The proportion of heavy smokers and overweight individuals was significantly higher in MS patients. Lebanese MS patients have risk factors similar to those in western countries. Older age and female gender were associated with a higher anti-VCA titer and male gender with a higher anti-EBNA-1. © 2015 Published by Elsevier Inc.
dc.identifier.doihttps://doi.org/10.1016/j.clim.2015.03.011
dc.identifier.eid2-s2.0-84928342558
dc.identifier.pmid25805657
dc.identifier.urihttp://hdl.handle.net/10938/31522
dc.language.isoen
dc.publisherAcademic Press Inc.
dc.relation.ispartofClinical Immunology
dc.sourceScopus
dc.subjectEpstein-barr virus
dc.subjectMultiple sclerosis
dc.subjectRisk factors
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAge factors
dc.subjectAged
dc.subjectAntibodies, viral
dc.subjectCapsid proteins
dc.subjectCase-control studies
dc.subjectEpstein-barr virus nuclear antigens
dc.subjectFemale
dc.subjectHerpesvirus 4, human
dc.subjectHumans
dc.subjectLebanon
dc.subjectMale
dc.subjectMiddle aged
dc.subjectMultiple sclerosis, chronic progressive
dc.subjectMultiple sclerosis, relapsing-remitting
dc.subjectOverweight
dc.subjectRetrospective studies
dc.subjectSex factors
dc.subjectSmoking
dc.subjectVitamin d
dc.subjectVitamin d deficiency
dc.subjectYoung adult
dc.subjectAntibody
dc.subjectEpstein barr virus antibody
dc.subjectGlatiramer
dc.subjectInterferon
dc.subjectMethylprednisolone
dc.subjectNatalizumab
dc.subjectUnclassified drug
dc.subject25-hydroxyvitamin d
dc.subjectCapsid protein
dc.subjectEpstein barr virus antigen
dc.subjectVirus antibody
dc.subjectAntibody titer
dc.subjectArticle
dc.subjectBlood sampling
dc.subjectBody mass
dc.subjectControlled study
dc.subjectDisease duration
dc.subjectEpstein barr virus
dc.subjectHuman
dc.subjectLebanese
dc.subjectMajor clinical study
dc.subjectObesity
dc.subjectPriority journal
dc.subjectRetrospective study
dc.subjectVitamin blood level
dc.subjectVitamin supplementation
dc.subjectAge
dc.subjectAnalogs and derivatives
dc.subjectBlood
dc.subjectCase control study
dc.subjectImmunology
dc.subjectRisk factor
dc.subjectSex difference
dc.titleRisk factors for multiple sclerosis and associations with anti-EBV antibody titers
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2015-10192.pdf
Size:
261.95 KB
Format:
Adobe Portable Document Format